Is the microbe - Dementia hypothesis finally ready for a treatment trial?

Neurology

Volumn 80, Issue 13, 2013, Pages 1182-1183

  Strandberg, Timo E ^a,b   Aiello, Allison E ^c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; VALACICLOVIR;

ALZHEIMER DISEASE; COGNITION; CYTOMEGALOVIRUS INFECTION; DEMENTIA; EDITORIAL; HERPES SIMPLEX ENCEPHALITIS; HUMAN; INFECTION; MICROBIAL COLONIZATION; NONHUMAN; PRIORITY JOURNAL;

COGNITION; COGNITION DISORDERS; FEMALE; HUMANS; INFECTION; INTERVIEWS AS TOPIC; MALE; MENTAL STATUS SCHEDULE;

EID: 84876236773     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182897126     Document Type: Editorial

References (10)

1. Miklossy J. Emerging roles of pathogens in Alzheimer disease. Expert Rev Mol Med Epub 2011 Sept 25.
2. Ball MJ. Limbic predilection in Alzheimer dementia: is reactivated herpesvirus involved? Can J Neurol Sci 1982;9: 303-306.
3. Itzhaki RF, Wozniak MA. Could antivirals be used to treat Alzheimer's disease? Future Microbiol 2012;7:307-309.
4. Solana R, Tarazona R, Aiello A, et al. CMV and immunosenescence: from basics to clinics. Immun Ageing Epub 2012 Oct 31.
5. Katan M, Moon YP, Paik MC, Sacco RL, Wright CB, Elkind MSV. Infectious burden and cognitive function: the Northern Manhattan Study. Neurology 2013;80:1209-1215.
6. Mussa FF, Chai H, Wang X, Yao Q, Lumsden AB, Chen C. Chlamydia pneumoniae and vascular disease: an update. J Vasc Surg 2006;43:1301-1307.
7. Dickerson F, Stallings C, Boronow JJ, Origoni A, Sullens A, Yolken R. Double blind trial of adjunctive valacyclovir in individuals with schizophrenia who are seropositive for cytomegalovirus. Schizophr Res 2009;107:147-149.
8. Prasad KM, Eack SM, Keshavan MS, Yolken RH, Iyengar S, Nimgaonkar VL. Antiherpes virus-specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trial. Schizophr Bull Epub 2012 Mar 23.
9. Strandberg TE, Pitkala KH, Tilvis RS, O'Neill D, Erkinjuntti T. Geriatric syndromes: vascular disorders? Ann Med Epub 2012 Oct 16.
10. Dickerson F, Stallings C, Origoni A, Vaughan C, Khuslani S, Yolken R. Additive effects of elevated C-reactive protein and exposure to herpes simplex virus type 1 on cognitive impairment in individuals with schizophrenia. Schizophr Res 2012;134:83-88.